Premium
The potential dangers of mephedrone in people with diabetes: a case report
Author(s) -
Wong Mo Lee,
Holt Richard IG
Publication year - 2011
Publication title -
drug testing and analysis
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.065
H-Index - 54
eISSN - 1942-7611
pISSN - 1942-7603
DOI - 10.1002/dta.316
Subject(s) - mephedrone , cathinone , diabetic ketoacidosis , diabetes mellitus , medicine , ketoacidosis , type 1 diabetes , drug , psychiatry , endocrinology , amphetamine , dopamine
Mephedrone is a cathinone derivative that has been used as a ‘legal high’ but was re‐classified in the UK as a class B (intermediate category) drug. This report describes an 18‐year‐old man with type 1 diabetes who developed ketoacidosis following self‐reported mephedrone use. Cathinone compounds may directly increase the risk of diabetic ketoacidosis by stimulating the central nervous system but may also indirectly impair an individual's ability to manage their diabetes through changes in cognitive function and behaviour.